Zymewire

FEBRUARY 8, 2024

Over t his period , Axonis has brought together and become world leaders in KCC2 biology , which has further separated us from our competition. To what extent has the prospect of a looming recession influenced your research & development strategy? It was a “Technology in Space” grant put together by the ISS NL , NASA, and Boeing.

Competition 52

Competition Leads Patients Marketing 52

PM360

APRIL 22, 2024

Meanwhile, spatial computing is an exciting prospect given its potential to simulate realistic medical scenarios. Such platforms attempt to make learning more enjoyable and motivate competition, hopefully leading to better retention of knowledge and skills.

Education 59

Education Physicians Healthcare Healthcare 59

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. As companies face the prospect of major revenue challenges over the next few years, securing inorganic growth through strategic alliances is increasingly attractive.

Pharma 59

Pharma Biopharma Prospecting Competition 59

Evolve Your Success

APRIL 11, 2023

My company standpoint is, “Online is the new prospecting tool.” ” When you look at the sales funnel, it has historically been sales reps going out and doing the prospecting and the top of the sales funnel as well as the bottom of the sales funnel. Online is the new prospecting tool. It’s very competitive.

Sales 52

Sales Medical Medical sales Media 52

Pharmaceutical Technology

MAY 22, 2023

The ongoing patent litigation between CureVac and Pfizer /BioNTech will move to a court in Virginia following a request from Curevac, potentially bringing forward the trial date to sometime in 2024. The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly.

Biopharma 116

Biopharma Prospecting Competition Pharmaceutical 116

Pharmaceutical Technology

JUNE 13, 2023

The company aims to then increase supplies in 2024. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Manufacturing 98

Manufacturing FDA Food and Drug Administration Pharmaceutical 98

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Samsung Bioepis and Organon previously stated that Hadlima's interchangeability data should be ready in 2024. Biosimilar uptake could be more gradual.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

MAY 5, 2023

The revised voluntary scheme has an expected launch on January 1, 2024. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Government 52

Government Medicine Medical sales Pharmaceutical 52

Pharmaceutical Technology

APRIL 4, 2023

With the latest funds, the company plans to advance its second ADC candidate to the Development Candidate Nomination (DCN) stage in H1 2024. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Prospecting 52

Prospecting Competition Healthcare Healthcare 52

Pharmaceutical Technology

FEBRUARY 17, 2023

In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

FDA 115

FDA Side effects Pharmacology Patients 115

Pharmaceutical Technology

APRIL 24, 2023

GlobalData predicts that Comirnaty’s sales will increase by more than 20% between 2024 and 2027. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Medicine 59

Medicine Pharmaceutical FDA Sales 59

Pharmaceutical Technology

DECEMBER 19, 2022

by the end of 2023 and may continue to rise in 2024 to 5%. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. JP Morgan predicts that the US unemployment rate could rise to 4.3%

Pharmaceutical 69

Pharmaceutical Manufacturing Government Medicine 69

Pharmaceutical Technology

JUNE 15, 2023

By the end of the year, the company will seek to identify similar issues in European biosimilars, followed by the Middle East and Africa in Q1 2024, and Asia Pacific in Q2. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Education 52

Education Patients Healthcare Healthcare 52

Pharmaceutical Technology

MARCH 29, 2023

The company expects to have data from both trials ready in mid-2024, says Thiroloix. Talks for this fundraise will likely start at the beginning of 2024, and the aim is to raise a significantly higher sum than in the previous rounds, confirms Thiroloix. Free Report How is the Biopharmaceutical industry evolving?

Recruitment 52

Recruitment Patients Prospecting Competition 52